Company Filing History:
Years Active: 2012
Title: Katsuhisa Murayama: Innovator in Drug Development
Introduction
Katsuhisa Murayama, based in Osaka, Japan, is a notable inventor recognized for his contributions in the field of drug development. With two patents to his name, he has significantly advanced methodologies in identifying target proteins and genes instrumental for drug discovery. His work not only showcases his inventive prowess but also emphasizes the importance of innovation in addressing health challenges.
Latest Patents
Katsuhisa Murayama's latest patents focus on the identification and application of novel target proteins and genes that facilitate drug discovery. One patent outlines a method for screening potential drugs, particularly aimed at developing new treatments for central nervous diseases, utilizing NCS proteins and genes. This innovation encompasses the mechanisms for producing drug derivatives, complexes involving drugs and NCS proteins, as well as kits for determining disease onset and drug susceptibility.
The second patent highlights a target protein known as CARP, which is pivotal for designing antiallergic drugs. It includes methods for screening therapeutic agents for allergic diseases and outlines production techniques for drug derivatives and their respective complexes. Additionally, it establishes protocols for assessing disease onset risks and a determination kit for drug susceptibility.
Career Highlights
Katsuhisa Murayama is associated with the Reverse Proteomics Research Institute Co., Ltd., where he collaborates to enhance drug discovery processes. His innovative spirit is reflected in his dual patents, both of which address crucial aspects of medical research and aim to facilitate the development of effective pharmaceutical agents.
Collaborations
In his professional journey, Murayama has collaborated with esteemed colleagues such as Tadakazu Yamauchi and Hideaki Sueoka. These partnerships serve to enrich his research endeavors and extend the impact of his inventions in the scientific community.
Conclusion
Katsuhisa Murayama stands out as a progressive inventor dedicated to advancing drug development through innovative means. His patents not only demonstrate his expertise but also contribute significantly to the ongoing fight against diseases through effective screening and the development of new pharmaceutical agents. His work reflects the profound potential of scientific innovation in improving health outcomes globally.